an Economist Intelligence Unit business healthcare About us Services Benefits Case Studies Resources Contact search Testimonials Chris Watts, Project Manager and Dr Jenny Gordon, Programme Manager, Evidence into Practice team, Royal College of Nursing “Bazian carried out a systematic review of evidence into the recognition and assessment of children’s pain as part of an update of a Royal College of Nursing clinical practice guideline. Bazian demonstrated an excellent understanding of the project brief, producing a high-quality and insightful report based on their development of a robust methodological approach and subsequent comprehensive review of the literature. Following delivery of the report, Bazian have continued to work with the RCN, providing helpful and timely support with further work on the guideline, as well as working with the project team to prepare the review for publication in an international peer reviewed journal. Bazian’s service to the RCN was always helpful, knowledgeable and timely and their contribution to the project will help to support and promote evidence based guidance on children’s pain assessment.” Dr Edmund Jessop, Medical Advisor National Commissioning Group “Bazian provided the national commissioning team with an analysis of policies used in various countries for the use of a set of very expensive drugs - enzyme replacement therapies for lysosomal storage disorders. The project was initiated to establish whether our policies were in line with international practice. Bazian understood the brief very well and delivered an excellent report in both quality and relevance. Project updates were appropriate and to the point. Bazian services were of an excellent quality and I would be happy to make use of their services again” Kate Caston, Director of East Midlands Specialised Commissioning “The work done on PAVR with Bazian brought together commissioners, clinicians and academics to ensure that the commissioning of this new, innovative procedure will be based on sound evidence. This will benefit future NHS patients, and has demonstrated that we can introduce new technologies through a robust research-led approach. It also provided a model for introducing innovations to the NHS in the future through a collaborative process based on World Class Commissioning.” Professor John Newton, Director of Public Health, South Central SHA “Bazian produced high quality reports within very tight time constraints and summarised their findings in a clear and concise manner. Whether to fluoridate or not was a contentious issue, and the level of scrutiny on information published by the SHA in the public domain was highly scrutinised both nationally and internationally. Bazian's independence from the SHA was important and their findings helped inform the Board paper on the scientific evidence of water fluoridation. The important work they carried out will be shared nationally with other SHA’s who may be carrying out similar consultations in the future.” Nat Billington, Managing Director of The Map of Medicine “Bazian’s focus on the evidence, the quality of their processes, and the personal commitment of individual members of their team have been invaluable in meeting our urgent demand for accurate, high quality and clinically relevant information.” Paul Nuki, Chief Editor, NHS Choices “Bazian demonstrate on a daily basis their ability to produce high-quality scientific appraisals for our news service within the extremely tight deadlines that are required of them. Their reliability and consistency are matched with a flexibility to cope with any ad hoc demands necessary for the service.” Dr Bob Coates, Director of Public Health, Hampshire Isle of Wight PCT “Bazian’s analyses helped health authorities tackle difficult decisions about how to handle new treatments and high cost procedures. Their independence was an important feature, especially in areas where controversial decisions were liable to provoke appeal, or in some instances judicial review.” Dr Steven Reid, Clinical Director for Psychological Medicine, Central and North West London NHS Foundation Trust “As the editor of EBMH I have been in the fortunate position of having Bazian survey over 50 medical journals each week without fail to provide an overview of the best available research in mental health. In addition the team have provided readable, distillations of the latest evidence that have become an essential component of the journal. Their rigorous approach to analysis, allied with their flexibility and responsiveness have made working with Bazian a pleasure and I would certainly welcome the opportunity to do so again.” David Bousfield, Electronic Publishing Services newsletter “Bazian have built a probability analysis environment which enables them to clearly indicate the likelihood that individual announcements are likely to be sustained as the direction in which the research will go - and thereby indicate to clinicians struggling through the current morass of research literature, clinical trials and reported general practitioner findings what the actual direction is going to be. In circumstances where no one can read all of the evidence, scientifically valid trend analysis is vital. Bazian has been building an enviable reputation here.” Brian Haynes MD, PhD, Editor, EvidenceUpdates “If you are looking for ways to help your patients who are the target of overzealous headlines, or looking for a critical analysis of topical news items, then try out Behind The Headlines. It is interesting, expertly prepared, and quickly available after articles in the lay press on science and health that may be misleading.” Simon Wessely, Professor of Psychological Medicine at the Institute of Psychiatry, King’s College London, and Honorary Consultant Psychiatrist at King’s and Maudsley Hospitals “Whilst overall the media did a pretty good job in reporting the paper […] they found it difficult to get the most important message of the paper across. Not so Behind The Headlines. Within hours appeared an elegant, detailed and clear outline of our paper, its strengths and weaknesses, and its main messages. And they were also able to immediately comment on one or two of the more inaccurate headlines as well. I wish I knew how they did it, but I hope that they continue in the same vein. I have learned also my lesson – now if I want impartial, swift, accurate and succinct analyses of recent major research, and want to know what it really means, but don’t have the time to turn to the original paper itself, I know exactly where to look.” Fiona Fox, Director, Science Media Centre “Both the Science Media Centre and the journalists we work with find Bazian’s analyses extremely useful; they help to put a scientific study into context, making immediately clear its strengths and limitations. The “Behind the Headlines” service is particularly useful not only to the public and health professionals, but also to those working in science communication and science media. It is a great source of information and analysis about the biggest health stories of the day – showing where and how they were covered in the media, and providing much needed background on where they came from in the first place. Many specialist health reporters follow the service, using examples of previous stories covered to help explain to their newsdesks why the context and rigour of scientific studies are important.” Katherine Jarman, Health Producer, BBC News “I find it very useful to read Bazian’s views on a study's strengths and limitations.” Lawrence McGinty, Health and Science Editor, ITV News “I think Bazian’s assessments are excellent and hit the right top notes. […] they could be fantastically useful in either getting a story on or, more likely, preventing scare stories.” The testimonials listed below relate to a project (CSAS), which provides a channel for commissioners to routinely consult in NICE’s technology appraisal process. Bazian’s role in the CSAS collaboration is to produce a high volume of regular, timely, high-quality evidence reports that enable effective commissioner consultation. Commissioner involvement is vital to the NICE process as it allows commissioners to discuss their perspective on the likely real-world clinical and cost implications of proposed new guidance. For further testimonials, and to see some of the reports (available only to NHS commissioners), see http://www.sph.nhs.uk/appraisals Andrew Donald, Director of GP Commissioning Development, South Staffordshire PCT “CSAS has simplified a very complex area in commissioning. This has provided PCTs with the knowledge and raised the importance of PCTs participating in NICE technology appraisals, which was not available prior to CSAS” Helen Seymour, Senior Medicines Management Adviser - NHS North of Tyne, Newcastle and Northumberland “CSAS has enabled me as the named PCT consultee to contribute to the consultation phases of NICE Technology Appraisals without the need for time consuming analysis of the data presented. If it wasn’t for the input from CSAS I believe that most PCTs would not have the time or resource to actively engage with NICE. CSAS has become a respected resource for evidence review.” Robert Brown, Specialist Pharmaceutical Advisor, NHS Eastern and Coastal Kent “CSAS has provided me with timely, well researched information enhancing my knowledge and enabling me to adequately represent the views of this commissioning organisation at a scoping meeting. […] I have used CSAS resources to help me with assessing individual funding requests and to inform business cases for medicine use in the absence of NICE appraisals” Neeshma Shah, Head of Medicines Management and Pharmacy, and Deputy CD Accountable Officer Medicines Management Team, NHS Camden “I have found CSAS very useful when responding to a consultation from NICE as a PCT consultee. The content provided by CSAS has matched PCT issues being considered when evaluating the evidence and impact of a new technology. CSAS should be strengthened to support Local Authorities overseeing aspects of commissioning in the new landscape.” About us Our team Publications EBM & evidology Testimonials Work with us Cookie policy News © 2014 Bazian | The Economist Intelligence Unit | Sitemap | Site by Redwire